CEBPA and fatty liver disease: Abnormalities in the liver, including adipogenic hepatic steatosis, induce the over-expression of this transcription factor and consequently induce the over-expression of several adipogenic genes, such as aP2 and C/ebp-α, in the hepatic tissue.